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Maternal Uniparental Disomy of Chromosome 1 with
No Apparent Phenotypic Effects
To the Editor:
Uniparental disomy (UPD) arises when an individual in-
herits two copies of a specific chromosome from one
parent and no copy from the other parent. This unusual
non-Mendelian transmission of parental genes may lead
to rare recessive disorders, or to developmental distur-
bances due to aberrant imprinting effects, in the zygote
(Ledbetter and Engel 1995). However, UPD may also
occur (at some unknown frequency) with no apparent
phenotypic consequences. Recently, the Journal re-
ported the first case of maternal chromosome 1 UPD
(Pulkkinen et al. 1997) and the first case of paternal
chromosome 1 UPD (Gelb et al. 1998), both ascertained
through a rare recessive condition. We report here the
third case of chromosome 1 UPD, and the first UPD to
be ascertained inadvertently during a genome-screen
linkage study. All three reports suggest that there are no
imprinted genes on chromosome 1 with a major effect
on phenotype.
The origin of UPD lies in meiotic nondisjunction
events. UPD can result from nondisjunction during mei-
osis I or II in one parent, leading to a disomic gamete,
followed by fertilization with a gamete nullisomic for
that chromosome from the other parent (gamete com-
plementation) or by postzygotic loss of the other parent’s
chromosome (trisomy rescue) (Engel 1993; Ledbetter
and Engel 1995). If the nondisjunction occurs at meiosis
I, the uniparental pair of chromosomes will contain the
centromeric regions of both of the parent’s homologues
(primary heterodisomy), whereas if the nondisjunction
occurs at meiosis II, the uniparental pair will contain
the replicated centromeric region of one of the parent’s
homologues (primary isodisomy). Exchanges during
meiosis I can introduce regions of homozygosity (sec-
ondary isodisomy) into a primary heterodisomy situa-
tion and, conversely, regions of heterozygosity (second-
ary heterodisomy) into a primary isodisomy situation.
In addition to meiosis I and II errors, a third mechanism
leading to UPD occurs when a normal monosomic gam-
ete is fertilized by a nullisomic gamete, followed by
postzygotic duplication of the single monosomic ho-
mologue (monosomy duplication)—this results in com-
plete chromosome isodisomy, including the centromere,
with no regions of heterozygosity (Engel 1993). Thus,
centromeric heterodisomy (heterozygous markers) in-
dicates a meiosis I error, whereas centromeric isodisomy
(homozygous markers) indicates either a meiosis II error
if there are other regions showing heterozygosity or post-
zygotic duplication if all other regions are homozygous.
Since the homozygosity associated with UPD, generated
either by primary or secondary isodisomy, consists of
duplicate copies of alleles from a single chromosome, it
carries an increased risk of homozygosity for deleterious
recessive genes. Indeed, the presence of a recessive dis-
ease in the offspring has been the mode of ascertainment
of many examples of UPD (reviewed in Pulkkinen et al.
1997). Similarly, if a chromosome carries imprinted
genes, so that one active allele at the imprinted locus is
necessary for normal growth and development of the
embryo, UPD may be associated with intrauterine
growth retardation and other developmental abnormal-
ities (reviewed in Hall 1990; Ledbetter and Engel 1995).
However, since the advent of comprehensive genome-
wide genotyping for purposes of genetic linkage analysis,
the possibility now exists that phenotypically “invisible”
cases of UPD, not ascertained through recessive disease
or through imprinting-associated abnormalities, will be
discovered.
We have been performing genome screening of fam-
ilies having at least two children affected with type 1
(insulin-dependent) diabetes, in order to identify by link-
age analysis genes predisposing to this disorder (Field et
al. 1994, 1996). A subset of 77 families including 203
children and all their parents has been typed for 187
markers across all chromosomes. During the course of
these studies, family BD94 (DNA obtained from the Brit-
ish Diabetes Association Warren Repository [Bain et al.
1990]) was noted to produce numerous marker-typing
incompatibilities between the second diabetic child and
her father. Closer inspection revealed that the incom-
patibilities between the father and the second child only
involved some of the 14 marker loci typed on chro-
mosome 1, whereas genotyping at 173 microsatellite loci
on chromosomes 2 through X (multiple markers on all
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Table 1






(Female cM) Mother Father Child1 Child2
D1S468 ) 4.5 1,2 1,1 1,2 1,2
D1S1612 ) 17.8 1,2 3,4 2,4 1,2a
D1S1368 ) ) 1,2 1,3 1,2 1,2
D1S1622 ) 68.5 1,1 2,3 1,2 1,1a
D1S186 ) 84.6 1,2 3,4 1,4 1,2a
D1S2134 ) 100 1,2 2,2 1,2 1,2
D1S405 ) 117 1,1 1,1 1,1 1,1
D1S3728 ) 122 1,1 2,2 1,2 1,1a
D1S198 p32-p33 132 1,2 3,4 2,4 1,2a
D1S159 p32 ) 1,2 2,3 2,3 1,1a,b
D1S410 ) 135 1,1 1,2 1,2 1,1
D1S1665 ) 137 1,2 1,3 1,1 2,2a,b
D1S550 ) ) 1,2 2,3 2,2 1,1a,b
D1S1728 ) 144 1,2 2,3 1,3 2,2b
D1S551 ) 151 1,1 1,2 1,1 1,1
D1S1159 ) 151 1,2 2,3 1,3 2,2b
D1S116 p21-p31 ) 1,1 1,2 1,1 1,1
D1S1588 ) 167 1,2 3,4 2,4 1,2a
AMY2B p21 ) 1,2 1,3 1,1 1,2
D1S1631 ) 177 1,2 2,3 1,2 1,2
D1S305 ) 210 1,1 2,3 1,3 1,1a
APOA2 q21-q23 227 1,2 3,4 1,4 1,2a
D1S1589 ) 245 1,2 1,3 2,3 1,2
D1S117 q23-q25 ) 1,2 3,3 1,3 1,2a
D1S1660 ) 271 1,2 3,4 2,3 1,2a
GATA124F08 ) ) 1,2 1,1 1,2 1,2
D1S213 q32-q44 312 1,2 3,4 2,4 1,2a
D1S103 q32-q44 317 1,2 3,4 2,4 1,2a
D1S547 ) 351 1,2 3,4 2,4 1,2a
HLA-A 1,2 3,31 1,31 1,31
HLA-B 8,62 65,60 8,60 8,60
HLA-C 7,3 8,3 7,3 7,3
HLA-DRB 3,4 13,4 3,4 3,4
HLA-DQB 2,3 1,8 2,8 2,8
  high risk HLA haplotype , , , ,
Type 1 diabetes present Yes No Yes Yes
a Incompatibility with father.
b Demonstrable maternal isodisomy.
chromosomes) produced no incompatibilities, proving
conclusively that the putative father was the biological
father. An additional 15 markers on chromosome 1 were
then genotyped for all family members, and further clin-
ical details about the family, particularly the second
child, were obtained following a separate informed con-
sent. Table 1 shows the results of typing 29 chromosome
1 markers and the human leukocyte antigen (HLA) types
provided by the BDA. For simplicity, genotypes are
shown as recoded alleles, with the mother’s alleles and
then the father’s alleles numbered from smallest to larg-
est and with alleles of identical size receiving the same
number code (for example, at D1S159, the mother is
145/147, the father 147/149, the first child 147/149, and
the second child 145/145). Markers are listed from pter
to qter, with positions on the female genetic map indi-
cated in centimorgans according to information from
the Marshfield Center for Medical Genetics Website.
Of the 29 chromosome 1 markers, 16 markers, dis-
tributed across the entire chromosome, show incom-
patibility (indicated in table 1) between the father and
the second diabetic child, labeled “Child2.” For all 29
markers, the second child’s genotype is either identical
to the mother’s genotype or (in a small region on the
short arm) shows only a single allele found in themother.
For the latter cases, if the mother is heterozygous but
the child is homozygous, then maternal isodisomy is pre-
sent (indicated in table 1). The centromeric region is
heterodisomic. This pattern is consistent with maternal
uniparental primary heterodisomy (arising from non-
disjunction during meiosis I), with an embedded region
of homozygosity (secondary isodisomy) on the short arm
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created by a double exchange event. The isodisomic re-
gion within the double exchange includes markers
D1S159, D1S410, D1S1665, D1S550, D1S1728,
D1S551, D1S1159, and possibly D1S116 (the mother is
uninformative for the latter), which have all been cyto-
genetically localized between 1p21 and 1p32. Advanced
maternal age is often associated with increased risk of
nondisjunction, but this is not relevant in the present
study, since the mother was 21 years old at the time of
the birth of her second child.
The region of homozygosity encompassed by the two
recombination events appears to be quite small: the es-
timated genetic distance between D1S159 and D1S1159
is 16–35 cM (see table 1: , and151 135  16 167
) in a total female-chromosome length of ∼365132  35
cM, according to the Marshfield maps. The other case
of maternal chromosome 1 UPD primary heterodisomy
also shows only a single region of secondary isodisomy
(∼35 cM on the long arm), created by a double meiotic
exchange event (Pulkkinen et al. 1997). It is possible
that unusual recombination patterns (e.g., decreased
number of chiasmata or closely adjacent chiasmata) pre-
dispose to nondisjunction in meiosis I and thus increase
the probability of UPD (Koehler et al. 1996). Alterna-
tively, possession of larger regions of homozygosity in
heterodisomic UPD zygotes would increase the risk of
recessive lethal conditions, so that these zygotes may be
selected against early in development. However, it also
is possible that the actual number of detected exchanges
(i.e., two) may not be particularly unusual. The expected
number of chiasmata occurring between chromatids of
paired homologues for a chromosome 365 cM long,
which is the size of chromosome 1, is on average seven.
We have calculated (on the basis of probabilities from
table 2 in Robinson et al. 1993) that the chance of ob-
serving ≤2 transitions in a UPD zygote, when seven chi-
asmata have occurred during meiosis, is 8.6%. (The term
“exchange” refers to a chiasma that has occurred in the
meiosis I tetrad, whereas “transition” refers to a tran-
sition from heterodisomy to isodisomy, or vice versa, in
a disomic gamete.) The probability of observing ≤2 tran-
sitions would be even higher if there was incomplete
marker coverage such that a transition event could be
missed (which is possible in the present study) and/or if
365 cM is an overestimate of the true map length due
to typing errors (genetic maps are commonly inflated for
this reason), so that the expected number of chiasmata
is actually less than seven. The reason that so few tran-
sitions might be observed, even if as many as seven chi-
asmata have taken place, is that for a transition to be
observable by extensive marker typing in a UPD zygote,
the exchange event must occur between a transmitted
and a nontransmitted chromatid (i.e., about half of ex-
changes result in potentially observable transitions,
when random involvement of chromatids in chiasmata
formation is assumed). Furthermore, for a transition to
be observable, the mother must be heterozygous for one
or more markers proximal to the exchange. Thus, al-
though it may seem that few exchanges have occurred
during the meiosis I event leading to this zygote with
chromosome 1 UPD, the actual number of transitions is
not significantly different from the expected number.
Trisomy 1 conceptuses have not been observed in
spontaneous abortions (Hassold et al. 1996), except for
one report of a lost pregnancy with no fetal development
(Hanna et al. 1997), or among cases of prenatally di-
agnosed placental or fetal mosaicism (Ledbetter et al.
1992; Teshima et al. 1992; Hahnemann and Vejerslev
1997). To our knowledge, there are only two reports of
trisomy 1 mosaicism in humans (outside of cancer cells)
(Neu et al. 1988; Howard et al. 1995). However, mo-
lecular studies to determine the origin of the trisomy
were not performed in either case, and in at least one
case both monosomy and trisomy 1 cells were present,
indicating that the trisomy arose as a somatic event dur-
ing development (Neu et al. 1988). On the other hand,
sperm or oocytes aneuploid for chromosome 1 are not
uncommon (Martin et al. 1991, 1995; Spriggs et al.
1996). This suggests that trisomy 1 conceptuses occur
but die prior to implantation. Thus, the finding of chro-
mosome 1 UPD of maternal meiotic origin is most likely
due to a gamete complementation mechanism (fertil-
ization of a disomic egg with a sperm nullisomic for
chromosome 1) rather than a trisomy-rescuemechanism
(postzygotic loss of the father’s chromosome 1), unless
the trisomy rescue occurred in the first one or two cell
divisions with complete selection against the trisomic
cells.
The mother and both of the two children in this fam-
ily have type 1 diabetes, and all three individuals have
HLA genotypes associated with a high risk of developing
diabetes (see table 1). It is well established that the HLA
region contains the strongest susceptibility genes for this
disease (for a review of insulin-dependent diabetes mel-
litus [IDDM] genetics, see Field and Tobias 1997). Thus,
we assume that the presence of chromosome 1 UPD in
one of the diabetic children is unrelated to her IDDM.
Apart from her diabetes, she has no other unusual con-
ditions. There was no evidence of dysmorphic features
at birth. She had a full-term birth weight of 2,930 g
(consistent with that of her mother and older brother,
whose full-term birth weights were 2,840 g and 2,870
g, respectively), with no indication of intrauterine
growth retardation. Subsequently (she is now 23 years
old), she showed no signs of mental or developmental
retardation or precocious puberty.
In the two other cases of chromosome 1 UPD (Pulk-
kinen et al. 1997; Gelb et al. 1998), ascertainment was
through a rare recessive disorder, but there were no fea-
tures suggestive of imprinting, such as growth or de-
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velopmental abnormalities. However, since the infant
with maternal chromosome 1 UPD died at 2 mo of age
(Pulkkinen et al. 1997), the present case of maternal
chromosome 1 UPD in a developmentally normal adult
provides valuable additional evidence that there are no
imprinted genes on chromosome 1 with major pheno-
typic effects. This has potential implications for prenatal
diagnosis if chorionic villus sampling (CVS) reveals tri-
somy mosaicism and later amniotic fluid sampling shows
fetal disomy (apparent trisomy rescue), since these cases
theoretically have a one in three risk of UPD for the
relevant chromosome and any associated imprinting ef-
fects (Ledbetter and Engel 1995). However, as discussed
above, it is probable that conceptuses trisomic for chro-
mosome 1 die before implantation and therefore are un-
likely to be detected by CVS.
The data presented here, combined with that from
other reports of UPD (Jones et al. 1995; Ledbetter and
Engel 1995), suggest that, in the absence of isodisomy
for recessive deleterious genes, uniparental disomy for
chromosomes that do not harbor imprinted loci may be
quite harmless. If so, it would be of interest to know the
frequency of this phenomenon in the normal general
population. In our laboratory, we have typed 1200 chil-
dren (and their parents) for markers relatively densely
distributed across the genome, and this is the first case
of UPD that we have recognized. Other laboratories per-
forming large-scale linkage-mapping projects may en-
counter UPD but may attribute it to lab typing errors,
null alleles, or nonpaternity. The possibility of UPD
should be considered when typing incompatibilities oc-
cur repeatedly for the same family in genome-screen pro-
jects, since such studies represent an important source
for discovery of additional cases of UPD with no ap-
parent phenotypic effects.
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